Anthem Blue Cross Blue Shield of California prior authorization J3590
Anthem Blue Cross Blue Shield of California prior authorization for J3590: Unclassified drugs or biologicals [when specified as eladocagene exuparvovec-tneq (Kebilidi)] or [when specified as an ocular gene therapy agent other than voretigene neparvovec-rzyl (Luxturna)] or [when specified as allogeneic processed thymus tissue-agdc (RETHYMIC) implant] or [when specified as etuvetidigene autotemcel (Waskyra)] or [when specified as a gene therapy for hemophilia other than Hemgenix, Beqvez, or Roctavian]
- Code
- J3590
- Description
- Unclassified drugs or biologicals [when specified as eladocagene exuparvovec-tneq (Kebilidi)] or [when specified as an ocular gene therapy agent other than voretigene neparvovec-rzyl (Luxturna)] or [when specified as allogeneic processed thymus tissue-agdc (RETHYMIC) implant] or [when specified as etuvetidigene autotemcel (Waskyra)] or [when specified as a gene therapy for hemophilia other than Hemgenix, Beqvez, or Roctavian]
- Source
- California PPO Prior Authorization List, Pg 26 Original policy
Anthem Blue Cross Blue Shield of California prior authorization